We're at the end of "The Next Stop" series, with our final stop at the American Society of Clinical Oncology (ASCO) Annual Meeting. 🚆 Watch to learn how we're exploring next-generation precision medicine approaches in oncology. #ASCO26
AbbVie
Pharmaceutical na Pagmamanupaktura
North Chicago, Illinois 2,027,044 (na) tagasubaybay
Tungkol sa amin
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- Website
-
http://www.abbvie.com
External na link para sa AbbVie
- Industriya
- Pharmaceutical na Pagmamanupaktura
- Laki ng kompanya
- 10,001+ na mga empleyado
- Headquarters
- North Chicago, Illinois
- Uri
- Pampublikong Kompanya
- Mga Specialty
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, Eye Care
Mga Lokasyon
Mga empleyado sa AbbVie
Mga update
-
The European Commission has granted AbbVie approval of our medicine as part of a combination regimen for previously untreated patients with chronic lymphocytic leukemia (#CLL). Click here to learn more: https://bit.ly/4dQ85Cb [Video description: On-screen text reads, “Oncology News.”]
-
We're focused on advancing the science of antibody-drug conjugates (#ADCs) for #cancer treatment. Explore our approach: https://bit.ly/3RDuYl0
-
Episode 8 of The Persistence Lab #podcast explores how evolving research approaches allow scientists to harness patients' clinical trial #data to better understand the biology of #AutoimmuneDiseases – and to inform targeted drug development. Hear how our scientists are helping shape the future of #immunology research: https://bit.ly/4x16frg 🎙️
-
Want to learn about immunology field training as a #career path with us? Tag along with Kyle R. through a day on the job. If you like what you see, check out our career opportunities: https://bit.ly/3RxkVOs #AbbVieLife
-
We're joining the global oncology community in Chicago for this year's American Society of Clinical Oncology (ASCO) Annual Meeting. Our team is eager to share new data across blood cancers and solid tumors from our novel platforms. These data highlight the growing momentum across our oncology pipeline and underscore our commitment to addressing unmet patient needs. Learn more: https://bit.ly/4upcT8G #ASCO26
-
Neurological disorders are complex—and #ParkinsonsDisease (PD) is among the fastest-growing neurological diseases worldwide. We’re at #WPC2026 reinforcing our commitment to advancing standards of care for people living with PD and elevating the conversation around policy changes needed for success. Learn more about how we’re taking action to help improve healthcare services and elevate care for the PD community: https://bit.ly/4v0fl5x
-
-
Tina works to challenge the status quo – both in how we discover and develop medicines. Learn how she’s advancing science with people in mind at AbbVie. https://bit.ly/4v5ox8Y
-
This #ClinicalTrialsDay, we celebrate the extraordinary clinical research community – the people pushing science forward for patients everywhere. Clinical research rises because dedicated people around the world keep showing up, innovating and persevering. Learn more about our work in clinical research: https://bit.ly/4dvt1zP
-
Every patient has a story that goes beyond their chart. This #WorldIBDDay, we are amplifying the perspectives of those living with #CrohnsDisease and #UlcerativeColitis worldwide. When patients can share their goals, daily realities, and what feeling well truly means to them, it creates the foundation for more meaningful care conversations and better outcomes. No one navigating IBD is alone. #IBDHasNoBorders
Mga Kaugnay na pahina
Kahalintulad na mga pahina
Pondo
AbbVie
2 (na) kabuuang round
Tingnan ang higit pang impormasyon sa crunchbase
Huling Round
Post IPO utang
External Crunchbase Link para sa last round ng funding
$15,000,000,000.00